Question 1

What’s the financial overview for MiNK Therapeutics, Inc.?

Accepted Answer

MiNK Therapeutics, Inc.’s market cap stands at $0.00 trillion right now. The company’s trailing twelve-month earnings per share EPS is $-2.46, with a dividend yield of N/A%. Their next earnings report is set for January 29, 2025, and the estimated EPS for that period is $1.61. You can also check out summaries of their income statement, balance sheet, and cash flow details for a fuller picture of their financials.

Question 2

How can I analyze historical data?

Accepted Answer

To analyze historical data with AI tools, apply the date range filter above the table to focus on a specific period. The table displays daily open, high, low, close prices, and volume, enabling you to spot trends and patterns. Use these insights to make informed decisions based on historical performance.

Question 3

What does MiNK Therapeutics, Inc. Stock ROE tell us?

Accepted Answer

MiNK Therapeutics, Inc. stock ROE shows positive market sentiment. A higher ROE means the company’s management is doing a better job at using equity financing to drive income and growth. It’s a handy metric for comparing how a company stacks up against its competitors or the broader market.

Question 4

What is per share price for MiNK Therapeutics, Inc.?

Accepted Answer

The MiNK Therapeutics, Inc. stock per share price is $64.17.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024
Revenue	$0.00	$0.00	$0.00	$0.00
Cost of Revenue	$0.00	$1.88B	$45100.00	$53831.00
Gross Profit	$0.00	-$1.88B	-$45100.00	-$53831.00
Gross Profit Ratio
R&D Expenses	$1.41M	$540638.00	$1.84M	$2.55M
SG&A Expenses	$808904.00	$1.16M	$1.06M	$1.23M
Operating Expenses	$2.50M	$1.88M	$3.07M	$3.78M
Total Costs & Expenses	$2.50M	$1.88M	$3.07M	$3.83M
Interest Income	$39573.00	$78015.00	$38360.00	$16619.00
Interest Expense	$0.00	$0.00	$0.00	$0.00
Depreciation & Amortization	$53869.00	$62637.00	$45100.00	$53831.00
EBITDA	-$2.16M	-$1.82M	-$2.86M	-$3.78M
EBITDA Ratio
Operating Income	-$2.50M	-$1.88M	-$3.07M	-$3.83M
Operating Income Ratio
Other Income/Expenses (Net)	$39573.00	$78015.00	$369275.00	$16619.00
Income Before Tax	-$2.46M	-$1.81M	-$2.70M	-$3.81M
Income Before Tax Ratio
Income Tax Expense	$0.00	$0.00	$0.00	$0.00
Net Income	-$2.46M	-$1.81M	-$2.70M	-$3.81M
Net Income Ratio
EPS	-$0.07	-$0.46	-$0.07	-$0.11
Diluted EPS	-$0.07	-$0.05	-$0.07	-$0.11
Weighted Avg Shares Outstanding	$3.96M	$3.95M	$37.14M	$34.64M
Weighted Avg Shares Outstanding (Diluted)	$3.96M	$39.53M	$37.14M	$34.64M

MiNK Therapeutics, Inc.